Zenas BioPharma (ZBIO) announced its 2024 accomplishments, outlined its key business objectives for 2025 and announced preliminary unaudited ...
RBC Capital keeps an Outperform rating and $235 price target on Alphabet (GOOGL) after its Q4 results. The quarter keeps the AI Search bear ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果